Nference
Cambridge, US · Delaware corporation · 2 known investors
Find your way into Nference
43 people in our graph share verified history with the Nference team — schools, employers, funds. One of them is your warm intro.
Travis Hughesunlockedknows Venky Soundararajan · together at nference (overlapped)
knows the team · via Anumana
×2knows the team · via nference
×8knows the team · via Indian Institute of Technology, Guwahati
nference works with medical centers to transform unstructured data from electronic medical records into tools that help scientists discover and develop personalized diagnostics and treatments. It serves biomedical researchers and healthcare organizations by curating and synthesizing biomedical data for scientific discovery.
Founders & leadership
VS
Venkataramanan SoundararajanCo-founder
MA
Murali AravamudaninCo-founder & CEO
AR
Ajit RajasekharaninCo-founder
VS
Venky SoundararajaninCo-founder & Chief Scientific OfficerVenky Soundararajan is co-founder and chief scientific officer of nference, which develops biomedical data software for scientific discovery and clinical research. He has also founded or led AI-enabled ventures in diagnostics and medical device development.
TM
Thomas McNaughtonNamed on SEC filing
JH
John HalamkaNamed on SEC filing
Board
DG
David GoelBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$12.3M disclosed across 2 rounds · 2020–2022
▶$2.7MraisedNov 2022 · 72 investors · BiotechnologyRule 506(b)
▶$2.7MraisedNov 2022 · 72 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas McNaughtonExecutive Officer
- Venkataramanan SoundararajanExecutive Officer
- Murali AravamudanExecutive Officer, Director
- John HalamkaDirector
- David GoelDirector
- Ajit RajasekharanExecutive Officer
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.6MraisedMar 2020 · 57 investors · BiotechnologyRule 506(b)
▶$9.6MraisedMar 2020 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Murali AravamudanExecutive Officer, Director
- Venkataramanan SoundararajanExecutive Officer
- Harris FishmanExecutive Officer
- Agustin MarquezExecutive Officer
- Andrew DanielsenDirector
- David GoelDirector
- Ajit RajasekharanExecutive Officer
- Tim BarrowsDirector
- Offering amount
- $9.6M
- Amount sold
- $9.6M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nference do?
- nference works with medical centers to transform unstructured data from electronic medical records into tools that help scientists discover and develop personalized diagnostics and treatments. It serves biomedical researchers and healthcare organizations by curating and synthesizing biomedical data for scientific discovery.
- Who founded Nference?
- Nference was founded by Venkataramanan Soundararajan, Murali Aravamudan, Ajit Rajasekharan, Venky Soundararajan.
- Who are Nference's investors?
- Nference's investors include NTT Venture Capital, Matrix.
- How much funding has Nference raised?
- Nference has disclosed $12.3M raised across 2 rounds.
- Where is Nference headquartered?
- Nference is headquartered in Cambridge, US.